{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:15:45Z","timestamp":1790910945061,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T00:00:00Z","timestamp":1464048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BBA Clinical"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bbacli.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T21:21:22Z","timestamp":1464297682000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance"],"prefix":"10.1016","volume":"6","author":[{"given":"Alexei","family":"Shimanovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argote J.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin A.","family":"Dasanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bbacli.2016.05.004_bb0005","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1158\/1055-9965.EPI-06-0097","article-title":"Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women","volume":"15","author":"Landgren","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"8","key":"10.1016\/j.bbacli.2016.05.004_bb0010","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 12","key":"10.1016\/j.bbacli.2016.05.004_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.bbacli.2016.05.004_bb0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1517\/14656566.9.9.1481","article-title":"Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice","volume":"9","author":"Dasanu","year":"2008","journal-title":"Expert. Opin. Pharmacother."},{"issue":"15","key":"10.1016\/j.bbacli.2016.05.004_bb0025","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1517\/14656566.2011.591381","article-title":"Autoimmune phenomena in untreated and treated marginal zone lymphoma","volume":"12","author":"Grabska","year":"2011","journal-title":"Expert. Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0030","first-page":"1119","article-title":"Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer","volume":"32","author":"Franks","year":"2012","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.exphem.2014.11.003","article-title":"Role of toll-like receptors in multiple myeloma and recent advances","volume":"43","author":"Thakur","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbacli.2016.05.004_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.3","article-title":"B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?","volume":"5","author":"Hengeveld","year":"2015","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1055-9965.EPI-13-0695","article-title":"Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review","volume":"23","author":"McShane","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"Suppl","key":"10.1016\/j.bbacli.2016.05.004_bb0050","first-page":"28","article-title":"Considerations regarding the pathogenesis of the plasmacytic dyscrasias","volume":"4","author":"Osserman","year":"1965","journal-title":"Scand. J. Haematol."},{"issue":"17","key":"10.1016\/j.bbacli.2016.05.004_bb0055","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ejca.2006.04.021","article-title":"Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden","volume":"42","author":"Soderberg","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0060","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/cncr.20441","article-title":"Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: a retrospective review","volume":"101","author":"Baz","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091461","article-title":"Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1","article-title":"Pernicious anemia and subsequent cancer. a population-based cohort study","volume":"71","author":"Hsing","year":"1993","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0075","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/bjc.1989.169","article-title":"Cancer risk following pernicious anaemia","volume":"59","author":"Brinton","year":"1989","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.bbacli.2016.05.004_bb0080","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1515\/CCLM.2005.201","article-title":"The potential cocarcinogenic effect of vitamin B12 deficiency","volume":"43","author":"Friso","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2010-04-279539","article-title":"Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma","volume":"117","author":"Walker","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0090","first-page":"251","article-title":"Clinical aspects of autoimmune hemolytic anemia","volume":"13","author":"Pirofsky","year":"1976","journal-title":"Semin. Hematol."},{"issue":"12","key":"10.1016\/j.bbacli.2016.05.004_bb0095","first-page":"469","article-title":"Myelomatosis and hemolytic anemia. Hemolytic anemia, a rare complication of multiple myeloma, is successfully managed by splenectomy","volume":"62","author":"Friedland","year":"1979","journal-title":"R. I. Med. J."},{"key":"10.1016\/j.bbacli.2016.05.004_bb0100","article-title":"Prevalence of autoimmune hemolytic anemia in multiple myeloma: a prospective study","author":"Kashyap","year":"2014","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10428190701385173","article-title":"Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas","volume":"48","author":"Hauswirth","year":"2007","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0110","first-page":"262","article-title":"Multiple myeloma associated with autoimmune hemolytic anemia","volume":"79","author":"Vaiopoulos","year":"1994","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","article-title":"Acquired pure red cell aplasia: updated review of treatment","volume":"142","author":"Sawada","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.bbacli.2016.05.004_bb0120","first-page":"1498","article-title":"Treatment of pure red cell aplasia associated with multiple myeloma with biclonal gammopathy using cyclosporine A: a case report","volume":"8","author":"Lv","year":"2015","journal-title":"Int. J. Clin. Exp."},{"issue":"10","key":"10.1016\/j.bbacli.2016.05.004_bb0125","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00277-013-1721-5","article-title":"Pure red cell aplasia associated with CD20+ myeloma: complete remission with rituximab","volume":"92","author":"So","year":"2013","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0130","first-page":"37","article-title":"Acquired pure red cell aplasia in patients with plasma cell neoplasm and long term remission with bortezomib therapy","volume":"3","author":"Sarathy","year":"2014","journal-title":"J. Hematol. Malig."},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2257.2000.00125.x","article-title":"Multiple myeloma and immune thrombocytopenia","volume":"22","author":"Gupta","year":"2000","journal-title":"Clin. Lab. Haematol."},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/1097-0142(19850901)56:5<1199::AID-CNCR2820560539>3.0.CO;2-8","article-title":"Multiple myeloma associated with immune thrombocytopenic purpura","volume":"56","author":"Verdirame","year":"1985","journal-title":"Cancer"},{"issue":"1 Suppl 2","key":"10.1016\/j.bbacli.2016.05.004_bb0145","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminhematol.2008.12.005","article-title":"Pathobiology of secondary immune thrombocytopenia","volume":"46","author":"Cines","year":"2009","journal-title":"Semin. Hematol."},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2169\/internalmedicine1962.29.512","article-title":"Evans' syndrome associated with gastric plasmacytoma: case report and a review of the literature","volume":"29","author":"Yonekura","year":"1990","journal-title":"Jpn. J. Med."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1445-5994.2009.01948.x","article-title":"Multiple myeloma complicated by Evans syndrome","volume":"39","author":"Yi","year":"2009","journal-title":"Intern. Med. J."},{"issue":"1","key":"10.1016\/j.bbacli.2016.05.004_bb0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clml.2011.11.001","article-title":"How to manage neutropenia in multiple myeloma","volume":"12","author":"Palumbo","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"1","key":"10.1016\/j.bbacli.2016.05.004_bb0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2009.03.006","article-title":"Autoimmune neutropenia in adults","volume":"9","author":"Akhtari","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.bbacli.2016.05.004_bb0170","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.clml.2013.08.002","article-title":"Autoimmune neutropenia in multiple myeloma and the role of clonal T-cell expansion: evidence of cross-talk between B-cell and T-cell lineages?","volume":"14","author":"Aryal","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajh.2830370307","article-title":"Light chain composition of serum granulocyte binding immunoglobulins","volume":"37","author":"Shastri","year":"1991","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10067-005-1089-6","article-title":"Light chain multiple myeloma in a patient with long-standing rheumatoid arthritis","volume":"24","author":"Alexopoulou","year":"2005","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ajh.20796","article-title":"Multiple myeloma presented as acute interstitial nephritis and rheumatoid arthritis-like polyarthritis","volume":"82","author":"Ardalan","year":"2007","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0959-8049(93)90188-L","article-title":"Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study","volume":"29A","author":"Eriksson","year":"1993","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbacli.2016.05.004_bb0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2177\/jsci.19.94","article-title":"A case of rheumatoid arthritis associated with multiple myeloma","volume":"19","author":"Inoue","year":"1996","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"1A","key":"10.1016\/j.bbacli.2016.05.004_bb0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0002-9343(85)90246-3","article-title":"Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort","volume":"78","author":"Katusic","year":"1985","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0205","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in systemic lupus erythematosus","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/17.3.512","article-title":"Family history of autoimmune disorders and cancer in multiple myeloma","volume":"17","author":"Linet","year":"1988","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/RHU.0b013e3181b0fe1e","article-title":"Multiple myeloma and systemic lupus erythematosus in a young woman","volume":"15","author":"Okoli","year":"2009","journal-title":"J. Clin. Rheumatol."},{"issue":"25","key":"10.1016\/j.bbacli.2016.05.004_bb0220","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbacli.2016.05.004_bb0225","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2011.10.024","article-title":"Hematological malignancy associated with polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.bbacli.2016.05.004_bb0230","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0235","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0049-0172(77)90033-6","article-title":"Acute dermatomyositis-polymyositis and malignancy","volume":"6","author":"Talbott","year":"1977","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0240","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0002-9343(75)90406-4","article-title":"Amyloidosis associated with dermatomyositis and features of multiple myeloma. The progression of amyloidosis associated with corticosteroid and cytotoxic drug therapy","volume":"59","author":"Zilko","year":"1975","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0245","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10245332.1999.11746437","article-title":"Malignancy: case report: muscle involvement in multiple myeloma: report of a patient presenting clinically as polymyositis","volume":"4","author":"Islam","year":"1999","journal-title":"Hematology"},{"key":"10.1016\/j.bbacli.2016.05.004_bb0250","doi-asserted-by":"crossref","first-page":"808474","DOI":"10.1155\/2010\/808474","article-title":"IgD multiple myeloma paraproteinemia as a cause of myositis","volume":"2010","author":"Colombo","year":"2010","journal-title":"Neurol. Res. Int."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0255","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","article-title":"Polymyositis, dermatomyositis and malignancy: a further intriguing link","volume":"9","author":"Zampieri","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0260","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mpo.2950200403","article-title":"Lymphoma in Sjogren's syndrome","volume":"20","author":"Pavlidis","year":"1992","journal-title":"Med. Pediatr. Oncol."},{"issue":"8","key":"10.1016\/j.bbacli.2016.05.004_bb0265","first-page":"e215","article-title":"Sjogren's syndrome associated with multiple myeloma","volume":"49","author":"Tazi","year":"2008","journal-title":"Singap. Med. J."},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0270","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/03009749509095171","article-title":"Sjogren's syndrome terminating with multiple myeloma","volume":"24","author":"Ota","year":"1995","journal-title":"Scand. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0275","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0280","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.130.6.2663","article-title":"High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome","volume":"130","author":"Moutsopoulos","year":"1983","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ard.44.2.109","article-title":"Demonstration and identification of monoclonal proteins in the urine of patients with Sjogren's syndrome","volume":"44","author":"Moutsopoulos","year":"1985","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.md.0000157398.37679.47","article-title":"Circulating monoclonal immunoglobulins in Sjogren syndrome: prevalence and clinical significance in 237 patients","volume":"84","author":"Brito-Zeron","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.bbacli.2016.05.004_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/art.39534","article-title":"Monoclonal gammopathy and risk of lymphoma and multiple myeloma in patients with primary Sjogren's syndrome","author":"Tomi","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0300","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0022-3859.81872","article-title":"An unusual cause for sicca syndrome","volume":"57","author":"Kulkarni","year":"2011","journal-title":"J. Postgrad. Med."},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/rheumatology\/36.3.401","article-title":"Ankylosing spondylitis associated with IgA lambda chain myeloma","volume":"36","author":"O'Neill","year":"1997","journal-title":"Br. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.bbacli.2016.05.004_bb0310","first-page":"726","article-title":"Association of ankylosing spondylitis with IgA-multiple myeloma: report of a case and pathogenetic considerations. Taiwan yi xue hui za zhi","volume":"88","author":"Lam","year":"1989","journal-title":"J. Formos. Med. Assoc."},{"issue":"27\u201330","key":"10.1016\/j.bbacli.2016.05.004_bb0315","first-page":"1335","article-title":"Association for ankylosing spondylarthritis multiple myeloma. A case history (author's transl)","volume":"55","author":"Blanc","year":"1979","journal-title":"Sem. Hop."},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0320","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5045\/kjh.2009.44.3.182","article-title":"The association between multiple myeloma and ankylosing spondylitis: a report of two cases","volume":"44","author":"Moon","year":"2009","journal-title":"Korean J. Hematol."},{"issue":"39","key":"10.1016\/j.bbacli.2016.05.004_bb0325","first-page":"2631","article-title":"Association of non-secreting myeloma and ankylosing spondylitis. Considerations on a clinical case","volume":"72","author":"Gualandi","year":"1981","journal-title":"Minerva Med."},{"issue":"9","key":"10.1016\/j.bbacli.2016.05.004_bb0330","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00296-009-1042-0","article-title":"Oligo-secretory myeloma in a patient with ankylosing spondylitis","volume":"30","author":"Perez-Pampin","year":"2010","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0335","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2230.2003.01324.x","article-title":"Leukocytoclastic (small vessel) vasculitis in multiple myeloma","volume":"28","author":"Bayer-Garner","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0340","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1468-3083.2004.01069.x","article-title":"Paraneoplastic vasculitis associated with multiple myeloma","volume":"18","author":"Sanchez","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0019-509X.49159","article-title":"Multiple myeloma with paraneoplastic leucocytoclastic vasculitis","volume":"46","author":"Jain","year":"2009","journal-title":"Indian J. Cancer"},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0350","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clml.2011.03.034","article-title":"Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing multiple myeloma: a case report","volume":"11","author":"Peterlin","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0355","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1684\/ejd.2010.1223","article-title":"Angiomatoid lesions (leukocytoclastic vasculitis) as paraneoplastic manifestations of multiple myeloma IgA lambda","volume":"21","author":"Carlesimo","year":"2011","journal-title":"Eur. J. Dermatol."},{"issue":"7","key":"10.1016\/j.bbacli.2016.05.004_bb0360","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00277-003-0804-0","article-title":"Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide","volume":"83","author":"Witzens","year":"2004","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.bbacli.2016.05.004_bb0365","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0025-6196(11)64890-8","article-title":"Association of temporal arteritis, retinal vasculitis, and xanthomatosis with multiple myeloma: case report and literature review","volume":"73","author":"Keung","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbacli.2016.05.004_bb0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-8722-5-59","article-title":"Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma","volume":"5","author":"Hemminki","year":"2012","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbacli.2016.05.004_bb0375","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0380","first-page":"472","article-title":"Monoclonal gammopathy associated with multiple sclerosis","volume":"8","author":"Tsung","year":"1978","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0385","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1191\/1352458504ms1091cr","article-title":"Waldenstrom's macroglobulinemia developing in a patient with multiple sclerosis: coincidence or association?","volume":"10","author":"Deftereos","year":"2004","journal-title":"Mult. Scler."},{"issue":"8\u20139","key":"10.1016\/j.bbacli.2016.05.004_bb0390","first-page":"554","article-title":"Late-onset multiple sclerosis and serum monoclonal gammopathy: an incidental association?","volume":"152","author":"Trefouret","year":"1996","journal-title":"Rev. Neurol."},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1532-5415.1989.tb05495.x","article-title":"Familial aggregation of multiple myeloma and central nervous system diseases","volume":"37","author":"Grufferman","year":"1989","journal-title":"J. Am. Geriatr. Soc."},{"issue":"9","key":"10.1016\/j.bbacli.2016.05.004_bb0400","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1080\/10428190410001663581","article-title":"Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma","volume":"45","author":"Urbanska-Rys","year":"2004","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0405","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0003-4975(00)01478-8","article-title":"Extramedullary plasmacytoma presenting with myasthenia gravis and mediastinal mass","volume":"70","author":"Ahmed","year":"2000","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0410","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0002-9343(69)90078-3","article-title":"Myasthenia gravis with a myeloma-type, gamma-G (IgG) immunoglobulin abnormality","volume":"46","author":"Rowland","year":"1969","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.bbacli.2016.05.004_bb0415","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0609.2008.01176.x","article-title":"A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma","volume":"82","author":"Dasanu","year":"2009","journal-title":"Eur. J. Haematol."},{"issue":"9","key":"10.1016\/j.bbacli.2016.05.004_bb0420","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3109\/10428194.2014.914203","article-title":"Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide","volume":"55","author":"Montefusco","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0425","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/13.6.1438","article-title":"Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies","volume":"13","author":"Montseny","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0430","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/ndt\/gfp032","article-title":"Membranous glomerulonephritis\u2014an under-reported histological finding in multiple myeloma","volume":"24","author":"Thachil","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.bbacli.2016.05.004_bb0435","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s005350050385","article-title":"Two cases of inflammatory bowel disease with multiple myeloma","volume":"34","author":"Minami","year":"1999","journal-title":"J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.bbacli.2016.05.004_bb0440","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s10620-006-9165-6","article-title":"Review article: multiple myeloma and inflammatory bowel disease","volume":"52","author":"Reynolds","year":"2007","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0445","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-10-1822","article-title":"From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention","volume":"17","author":"Landgren","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbacli.2016.05.004_bb0450","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/1756-185X.12267","article-title":"A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: is there a link between the two diseases?","volume":"17","author":"Cho","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"issue":"24","key":"10.1016\/j.bbacli.2016.05.004_bb0455","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","article-title":"Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study","volume":"118","author":"Lindqvist","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbacli.2016.05.004_bb0460","first-page":"65","article-title":"Monoclonal gammapathy of undetermined significance and autoimmune disease: description of three cases in Senegal","volume":"68","author":"Diallo","year":"2008","journal-title":"Med. Trop."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0465","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.1992.tb00570.x","article-title":"Autoimmune reactions in patients with M-component and peripheral neuropathy","volume":"232","author":"Jonsson","year":"1992","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.bbacli.2016.05.004_bb0470","first-page":"327","article-title":"Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia","volume":"10","author":"Jonsson","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.bbacli.2016.05.004_bb0475","series-title":"ASCO Annual Meeting Proceedings","article-title":"Role of immune-related conditions in smoldering myeloma and MGUS","volume":"vol. 30 No. 15_suppl.","author":"Kwok","year":"2012"},{"issue":"4","key":"10.1016\/j.bbacli.2016.05.004_bb0480","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res."}],"container-title":["BBA Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T17:00:36Z","timestamp":1692378036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214647416300253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":96,"alternative-id":["S2214647416300253"],"URL":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.05.004","relation":{},"ISSN":["2214-6474"],"issn-type":[{"value":"2214-6474","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance","name":"articletitle","label":"Article Title"},{"value":"BBA Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}